BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
about
Therapeutic Implications of Targeting AKT Signaling in MelanomaModulation of the Akt pathway reveals a novel link with PERK/eIF2α, which is relevant during hypoxiaBI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting AktActivation of the PI3K/AKT pathway in Merkel cell carcinomaInhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.Identification of small molecules that interfere with H1N1 influenza A viral replication.Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathwaysThe Akt signaling pathway: an emerging therapeutic target in malignant melanoma.SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation ComplexThe PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanoma.Role of PRAS40 in Akt and mTOR signaling in health and disease.Design, synthesis, and structure-activity relationships of 3-ethynyl-1H-indazoles as inhibitors of the phosphatidylinositol 3-kinase signaling pathwayCooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
P2860
Q24631438-4E66774D-915E-4116-94C2-7256C1398D61Q28534963-ED045E8E-CC99-4541-AE76-8EEDB83932D1Q33877402-DE991AE0-06FC-4DEF-B71C-397627AF3BE8Q34170708-C94D88C1-EBE1-4F03-B94D-A4B7B149AE8EQ34433459-6E0FD083-60D7-496D-AD91-AB455DC93428Q34471507-28986EB9-ABB2-44B2-BC38-04A7E423BD28Q35172795-84B67876-404F-49E3-ABFC-61DBA2D0AD43Q35911227-88B91DA3-09E5-4D07-86B3-E1B4289DAFBAQ36378135-875C8EC7-CBBE-4C85-8F12-C46888082A0CQ37506648-FACE41EF-31B6-4B03-9AAB-E5DDCDCE9935Q37664921-A86F01E2-F332-414E-A36D-AEE78D758F01Q37987085-57FC50AF-45BB-4D37-9CFC-3BCA3B0758EBQ39634158-2F0A99AD-A035-4064-92CC-7C10D32FAC73Q55035474-0C5A1B52-C922-4386-BB64-9FE89D96C632
P2860
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@en
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@nl
type
label
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@en
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@nl
prefLabel
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@en
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.
@nl
P2093
P2860
P1476
BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma
@en
P2093
Antimone Dewing
Hongbin Yuan
Marianna Tcherpakov
Maurizio Pellecchia
Megan Riel-Mehan
Stan Krajewski
Supriya Gaitonde
Surya K De
P2860
P304
P356
10.1111/J.1755-148X.2009.00544.X
P577
2009-01-17T00:00:00Z